Result: Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2025

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

Research and practice in thrombosis and haemostasis. - 8, 5 (2024) , 102534, ISSN: 2475-0379

*DOI*:

10.1016/j.rpth.2024.102534

*Result*: Long-term course of ambulatory patients with COVID-19 initially treated with enoxaparin vs no anticoagulation: final analysis of the OVID (enoxaparin for outpatients with COVID-19) randomized trial